Chlamydia trachomatis and Neisseria gonorrhoeae Multiplex

Cat no. YSL-qPX-EC-CT.NG-100

Chlamydia trachomatis and Neisseria gonorrhoeae Multiplex

Cat no. YSL-qPX-EC-CT.NG-100

A multiplex qPCR kit for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae

Neisseria gonorrhoeae;Chlamydia trachomatis: Neisseria gonorrhoeae and Chlamydia trachomatis are common sexually transmitted infections in humans, causing symptoms such as urethral discharge, pain during urination, and pelvic inflammatory disease. These pathogens belong to the human health sector and early detection is crucial to prevent the spread of the diseases and potential complications such as infertility and ectopic pregnancy.

YouSeq's qPCR kit to detect Neisseria gonorrhoeae and Chlamydia trachomatis allows for sensitive and specific detection of these pathogens, enabling rapid diagnosis and treatment. Early detection of these infections is essential in preventing further transmission and serious health consequences, underscoring the importance of YouSeq's accurate and efficient detection methods.

United States FlagAvailable for delivery in United States

Price on enquiry

Order now

For Research Use Only. Not intended for diagnostic use.

Contents


Target specific primer/probe mix, including endogenous control
qPCR MasterMix
Positive control template
DNase/RNase free water
Template resuspension buffer

Technical specification


Target Gene(s):methyltransferase gene,Control gene
Efficiency: 90-110%
Sensitivity: <100 copy detection
Run Time: Approx 1hr30 (dependent on instrumentation)

Product variants


YSL-qPX-EC-CT.NG-100 : Lyophilised version for ambient shipping
YS-qPX-EC-CT.NG-100 : Frozen version for dry ice shipping

Pseudonyms

Chlamydia trachomatis; Neisseria gonorrhoeae; Chlamydia; Gonorrhea; CT; NG; The Clap; Chlamydia in the eye; GC; Non-specific urethritis; NSU; Urethritis; NGU; The Drip; The Clap

Related products

More products

Still scrolling? We love adventurers

We work at the cutting edge of molecular biology, striving to disrupt our industry. We drive continuous product innovation and we aren’t afraid to take on new challenges.

More about us

Related learning resources